“Nature’s Ozempic”: Berberine, GLP-1 “Boosters” and What the Evidence Says

Smiling pharmacist with a turban assisting at the pharmacy counter.

Written by

marketing

in

,

Myth-buster

Berberine for Weight Loss: evidence, risks and interactions Dietary supplement: not FDA approvedEvidence: LimitedGreen Tea Extract: small effects and liver warnings Dietary supplement: not FDA approvedEvidence: LimitedFiber Supplements for Weight Loss: psyllium, glucomannan and more Dietary supplement: not FDA approvedEvidence: Moderate

"Nature's Ozempic" checked: what trials show for berberine and other GLP-1 "boosters", how they compare with semaglutide, and what the FDA and FTC have done.

By marketing Updated October 7, 2026 Facts checked October 6, 2026

Fact-checked against FDA labels and official sources; not yet reviewed by a licensed clinician. This page is education, not medical advice. Talk to your doctor before starting, stopping or changing any treatment.

Key takeaways

  • In pooled trials, berberine led to about 0.9 to 2 kg more weight loss than placebo, and two analyses found no significant effect.[3]
  • Semaglutide 2.4 mg led to 14.9% average weight loss vs 2.4% with placebo over 68 weeks in STEP 1.[1]
  • Goldenseal extract (which contains berberine) lowered metformin levels by about 25%, and NIH says it should not be used in pregnancy, breastfeeding or infants.[8]
  • The FDA sent a warning letter in December 2024 to a seller of "GLP-1" drops that claimed FDA approval and up to 52 pounds lost in 3 months.[19]
  • The FDA does not approve dietary supplements before they are sold.[22]

In short: No supplement works like Ozempic. Berberine, the plant compound social media nicknamed “nature’s Ozempic”, led to roughly 1 to 2 kg (2 to 4.5 lb) more weight loss than placebo in pooled trials, and some analyses found no significant effect, while semaglutide 2.4 mg led to about 12.7 kg more than placebo in its main trial. Products sold as “GLP-1 boosters” or “GLP-1 support” do not contain GLP-1 medicine, and the FDA does not approve any supplement before it is sold.

A doctor and patient having a friendly conversation in a modern clinic.
Photo: Cedric Fauntleroy / Pexels

This page checks the “nature’s Ozempic” claims against the research and the regulators. For the full record on the most talked-about ingredient, see our berberine guide; for how prescription GLP-1 medicines work, see GLP-1 medications. It is general education, not individual advice: if you are considering any supplement, especially with diabetes medicines or other prescriptions, talk with your clinician or pharmacist first.

Where “nature’s Ozempic” came from

The nickname took off on TikTok in the spring and summer of 2023, as Ozempic and Wegovy shortages and prices made headlines. By late June 2023, CBC News reported that the hashtag #NaturesOzempic had more than 12.2 million views. Most videos were about berberine; since then the label has spread to fiber pills, probiotics, citrus and saffron extracts, yerba mate and even skin patches. The appeal is easy to understand: a cheap, natural capsule that does what a prescription injection does. The research tells a different story.

What Ozempic and Wegovy actually do

Ozempic and Wegovy contain semaglutide, a lab-made version of the gut hormone GLP-1. The FDA label describes it as a GLP-1 analogue with 94% sequence similarity to human GLP-1 that binds to and activates the GLP-1 receptor, including in brain areas that regulate appetite. The key difference from your own GLP-1 is how long it lasts: semaglutide is built to bind to a blood protein (albumin), which the label says protects it from breakdown; its elimination half-life is about one week. That long half-life is why semaglutide works as a once-weekly injection; Wegovy also comes as a daily 25 mg pill.

In the STEP 1 trial, 1,961 adults with obesity or overweight used semaglutide 2.4 mg or placebo for 68 weeks alongside lifestyle support. Average weight fell 14.9% with semaglutide and 2.4% with placebo, a difference of 12.7 kg (about 28 lb). Semaglutide also carries a boxed warning about thyroid C-cell tumors seen in rodents, and it needs a prescription because its effects, side effects and interactions need medical oversight. Read more in our Wegovy and Ozempic guides.

Extra weight lost vs placebo: semaglutide and the most-hyped supplementsValues in kg
Extra weight lost vs placebo: semaglutide and the most-hyped supplements
ItemValue
Semaglutide 2.4 mg (STEP 1, 68 weeks)12.70 kg
Berberine (23 trials, pooled)0.88 kg
Glucomannan (8 trials, pooled; not significant)0.22 kg
Green tea preparations outside Japan (6 trials; not significant)0.04 kg

Different trials, people and durations: this is not a head-to-head comparison. It shows the size of the effects each body of research found.

Source: Wilding et al., NEJM 2021; Elahi Vahed et al., Int J Obes 2026; Onakpoya et al., J Am Coll Nutr 2014; Jurgens et al., Cochrane 2012 (checked on October 6, 2026)

Berberine: what the trials found

Berberine is a bitter yellow compound found in plants such as goldenseal and barberry. It has been studied mostly for blood sugar and cholesterol, and some lab research suggests effects on metabolism, but it is not a GLP-1 medicine and not FDA approved for weight loss. Here is what pooled human trials report for weight:

AnalysisTrialsWeight vs controlWhat else it found
Elahi Vahed et al., International Journal of Obesity, 202623 randomized trials-0.88 kg (about 2 lb)BMI -0.48; waist -1.32 cm; authors called for better trials and better reporting of product purity and dose
Asbaghi et al., Clinical Nutrition ESPEN, 202012 studies-2.07 kg (about 4.5 lb)BMI -0.47; waist -1.08 cm
Xiong et al., Complementary Therapies in Clinical Practice, 202010 studies-0.11 kg, not significantSmall drops in BMI and waist
Amini et al., Complementary Therapies in Medicine, 202012 trials, 849 people-0.11 kg, not significantNo significant change in BMI or waist

An umbrella review of 11 berberine meta-analyses, published in 2023, rated their methods and concluded that the reported effects “need to be confirmed in high-quality” randomized trials. In plain terms: berberine might help a little, the trials are small and uneven, and the best-case effect is a fraction of what prescription GLP-1 medicines do.

Evidence that berberine helps with weight lossPartly established: small, inconsistent effect

Berberine’s safety and interactions

  • Drug interactions. In healthy men taking 300 mg three times a day for two weeks, berberine reduced the activity of three liver enzymes (CYP2D6, CYP2C9 and CYP3A4) that clear many common medicines. In kidney-transplant patients, berberine raised blood levels of the anti-rejection drug cyclosporine by about 29%.
  • Metformin. NIH’s complementary health center reports that metformin levels fell about 25% in healthy adults given goldenseal extract (which contains berberine) plus metformin.
  • Pregnancy, breastfeeding and babies. NIH says people who are pregnant or breastfeeding should not use goldenseal, it should not be given to infants, and its berberine “can be harmful to newborns”.
  • Stomach upset. Constipation and diarrhea are the side effects most often reported in the trials.
  • Blood sugar. Because berberine is studied for lowering blood sugar, combining it with diabetes medicines is a conversation to have with your prescriber first.

Other “GLP-1 boosters”, checked

These are the other ingredients most often sold as natural GLP-1 helpers. We rate each one by how well weight loss is established in human research, the same way our supplements hub does: established, partly established or not established. None is “established”.

Ingredient or product typeThe claimWhat the evidence saysWeight claim
Berberine“Nature’s Ozempic”About 0 to 2 kg more than placebo in pooled trials; low-quality evidencePartly established
Psyllium and other gel-forming fiberFills you up, “boosts GLP-1”Small losses in some pooled trials; one positive 2023 analysis was written by employees of a psyllium maker. See our fiber supplements pagePartly established
Glucomannan (konjac fiber)Expands in the stomach8 trials: -0.22 kg, not significant; NIH: “little to no effect”, and tablets can block the esophagusNot established
Green tea extractBurns fatCochrane: -0.04 kg in trials outside Japan; extracts linked to liver injury. See green tea extractNot established
“GLP-1” probioticsRaise your own GLP-1NIH: inconsistent effects on weight. One leading brand’s page says its GLP-1 claims are based on preclinical studies and the product is “not intended for weight loss”Not established
Citrus and saffron “GLP-1 support” capsules“Supports GLP-1 production”Small trials measured GLP-1 levels; one found no change in body measurements. A best-known product’s own page calls it “not a weight loss supplement”Not established
Yerba mateAppetite and fat-burningA 2025 analysis of 13 trials found no significant effect on BMI or waist; side effects included insomnia and a fast heartbeatNot established
“GLP-1 patches”Absorbed through the skinNo published trials. The FTC’s consumer advice: “Nothing you can wear or apply to your skin will cause you to lose weight. Period.”Not established

Notice the careful wording on many labels: “GLP-1 support”, “supports healthy GLP-1 levels”, “not a GLP-1 agonist drug”. Raising your own GLP-1 a little after a meal is not the same as taking a long-acting medicine that keeps the receptor switched on all week. Eating protein- and fiber-rich meals is a reasonable, food-first way to feel fuller; our list of the most filling foods and our high-protein diet guide show how, without a supplement.

What regulators have actually done

Under U.S. law, the FDA “does not have the authority to approve dietary supplements before they are marketed.” Makers are responsible for safety and truthful labels, and the FDA and the Federal Trade Commission (FTC) act afterward. Here is what each has done that bears on “nature’s Ozempic” products, described exactly as issued:

  • FDA warning letter to Veronvy (December 10, 2024). The FDA told the seller of “Elily Veronvy” drops that the products were unapproved new drugs and misbranded. Claims quoted in the letter included that the drops “helped people lose up to 52 pounds in 3 months during clinical trials and was approved by the Food and Drug Administration last year” and a section titled “The Science of GLP-1”. A warning letter is a formal notice, not a court ruling.
  • FDA warnings about unapproved GLP-1 drugs. The FDA has warned companies selling semaglutide, tirzepatide and retatrutide labelled “for research purposes” or “not for human consumption”, and has reported counterfeit Ozempic. These are drugs sold outside the legal system, not supplements, but they are often marketed in the same places.
  • FDA’s tainted weight-loss products list. The FDA keeps a running list of weight-loss products found to contain hidden drugs and says it “covers only a small fraction” of contaminated products on the market. According to NIH, the hidden ingredient is often sibutramine, a weight-loss drug withdrawn from the U.S. market in 2010.
  • FTC. We found no FTC case aimed specifically at “GLP-1” or “nature’s Ozempic” supplements as of October 6, 2026. The FTC’s 2022 Health Products Compliance Guidance says it generally expects health claims to be backed by high-quality randomized, controlled human trials. In 2025 the FTC finalized an order against NextMed, a telehealth seller of GLP-1 drug programs (not a supplement company), over allegedly deceptive weight-loss claims, fake reviews and before-and-after photos.

The rules in three numbers

Checked on October 6, 2026

How to spot a “nature’s Ozempic” claim that doesn’t hold up

Five quick checks

  1. "FDA approved" on a supplementSupplements are not approved before sale; a supplement claiming FDA approval for weight loss is a red flag.
  2. GLP-1 in the nameAsk whether it contains a GLP-1 medicine. Supplement makers' own fine print usually says it does not.
  3. Big numbers, no trial"Lose 50 pounds" with no published, randomized human trial behind it.
  4. Wear it or rub it onPatches, creams and wraps don't cause weight loss, per the FTC.
  5. Sold as "research only"Injectable peptides labelled "not for human consumption" are unapproved drugs, not supplements.

You can also look up a product in the FDA’s tainted-products notices, and check our evidence ratings for fat burners and other weight-loss supplements. For more claims we have checked, see 12 weight-loss myths science has busted.

What does work, if you want a GLP-1-style effect

If you are drawn to “nature’s Ozempic” because you want the appetite effect of a GLP-1 medicine, the honest options are prescription ones, used with a clinician. Our every FDA-approved weight-loss medication compared page lays them out side by side, the weight-loss pills guide covers the oral options, and compounded GLP-1s explains the risks of cheaper versions. Coverage and cost are often the real barrier; our insurance and cost guides can help. If medication isn’t right for you, the foundations still work: a modest calorie deficit, protein and fiber at meals, regular activity and enough sleep. Start with how to lose weight.

Records in this article

Dietary supplement: not FDA approvedEvidence: LimitedBerberine for Weight Loss: evidence, risks and interactionsEvidence: LimitedDietary supplement: not FDA approvedEvidence: LimitedGreen Tea Extract: small effects and liver warningsEvidence: LimitedDietary supplement: not FDA approvedEvidence: ModerateFiber Supplements for Weight Loss: psyllium, glucomannan and moreEvidence: ModerateFDA approved for weight managementPrescriptionInjectionWegovy (semaglutide): uses, side effects, cost and FDA statusSemaglutide: one ingredient, several brands · Injection · WeeklyHigh-Protein Diet for Weight Loss: how much and from whatEvidence: Moderate · Moderate

Related guides

GLP-1 Medication vs a Diet Program: Results, Costs and Trade-offsGLP-1 medication vs a diet program compared: average weight loss in STEP, SURMOUNT, Look AHEAD and…Fiber Supplements Compared: Psyllium vs Glucomannan vs Inulin (Rated by Evidence)Fiber supplements compared and rated by evidence for weight: psyllium, inulin, beta-glucan, glucomannan, guar gum, wheat…Ozempic vs Mounjaro: How the Two Diabetes Drugs DifferOzempic vs Mounjaro compared from the FDA labels and the SURPASS-2 head-to-head trial: approved uses, how…Whey vs Plant Protein for Weight LossWhey vs plant protein for weight loss: protein quality (DIAAS), muscle trials, the one weight head-to-head,…

Questions to ask a professional

  • Could berberine interact with any of my medicines?
  • Am I a candidate for an FDA-approved weight-loss medication?
  • How would I know if a GLP-1 product online is legitimate?
  • What can I do about the cost or coverage of a prescription option?
  • Which food and activity changes would help me most right now?

Frequently asked questions

Is berberine really "nature's Ozempic"?

No. Berberine is not a GLP-1 medicine. Pooled trials found about 0.9 to 2 kg more weight loss than placebo at best, and some found none, compared with about 12.7 kg more than placebo for semaglutide 2.4 mg in STEP 1.

Do GLP-1 supplements contain GLP-1?

No. Supplements sold as "GLP-1 support" or "boosters" do not contain GLP-1 medicine; leading makers state on their own pages that their products are not GLP-1 agonist drugs.

Is berberine safe to take with metformin?

Ask your prescriber first. NIH reports that goldenseal extract, which contains berberine, lowered metformin levels by about 25%, and berberine also affects liver enzymes that clear many medicines.

Has the FDA or FTC acted against "nature's Ozempic" products?

The FDA sent a warning letter in December 2024 to a seller of "GLP-1" drops that claimed FDA approval. We found no FTC case aimed specifically at GLP-1 supplements as of October 2026; the FTC expects health claims to be backed by quality human trials.

Are there natural ways to raise GLP-1?

Meals with protein and fiber help you feel full, and your body makes its own GLP-1, but no food or supplement has been shown to act like a long-acting GLP-1 medicine. Food-first habits support weight loss without the risks of unregulated products.

References

  1. WEGOVY (semaglutide) injection and tablets: prescribing information. Novo Nordisk, via DailyMed, 2026. (accessed October 7, 2026) Drug label
  2. Wilding JPH, Batterham RL, Calanna S, et al.. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). New England Journal of Medicine, 2021. doi:10.1056/NEJMoa2032183 · PMID 33567185 · NCT03548935 (accessed October 7, 2026) Randomized trial
  3. Elahi Vahed I, Shahir-Roudi E, Nojumi S, et al.. The effect of berberine on obesity indices: a systematic review and meta-analysis. International Journal of Obesity, 2026. doi:10.1038/s41366-025-01943-x · PMID 41310257 (accessed October 6, 2026) Meta-analysis
  4. Asbaghi O, Ghanbari N, Shekari M, et al.. The effect of berberine supplementation on obesity parameters, inflammation and liver function enzymes. Clinical Nutrition ESPEN, 2020. doi:10.1016/j.clnesp.2020.04.010 · PMID 32690176 (accessed October 6, 2026) Meta-analysis
  5. Xiong P, Niu L, Talaei S, et al.. The effect of berberine supplementation on obesity indices: a dose-response meta-analysis. Complementary Therapies in Clinical Practice, 2020. doi:10.1016/j.ctcp.2020.101113 · PMID 32379652 (accessed October 6, 2026) Meta-analysis
  6. Amini MR, Sheikhhossein F, Naghshi S, et al.. Effects of berberine and barberry on anthropometric measures: A systematic review and meta-analysis of randomized controlled trials. Complementary Therapies in Medicine, 2020. doi:10.1016/j.ctim.2020.102337 · PMID 32147051 (accessed October 6, 2026) Meta-analysis
  7. Li Z, Wang Y, Xu Q, et al.. Berberine and health outcomes: An umbrella review. Phytotherapy Research, 2023. doi:10.1002/ptr.7806 · PMID 36999891 (accessed October 6, 2026) Review
  8. Goldenseal: usefulness and safety. NCCIH (NIH). (accessed October 6, 2026) Government page
  9. Guo Y, Chen Y, Tan ZR, et al.. Repeated administration of berberine inhibits cytochromes P450 in humans. European Journal of Clinical Pharmacology, 2012. doi:10.1007/s00228-011-1108-2 · PMID 21870106 (accessed October 6, 2026) Other
  10. Wu X, Li Q, Xin H, et al.. Effects of berberine on the blood concentration of cyclosporin A in renal transplanted recipients: clinical and pharmacokinetic study. European Journal of Clinical Pharmacology, 2005. doi:10.1007/s00228-005-0952-3 · PMID 16133554 (accessed October 6, 2026) Other
  11. Onakpoya I, Posadzki P, Ernst E. The efficacy of glucomannan supplementation in overweight and obesity. Journal of the American College of Nutrition, 2014. doi:10.1080/07315724.2014.870013 · PMID 24533610 (accessed October 7, 2026) Meta-analysis
  12. Jurgens TM, Whelan AM, Killian L, et al.. Green tea for weight loss and weight maintenance in overweight or obese adults. Cochrane Database of Systematic Reviews, 2012. doi:10.1002/14651858.CD008650.pub2 · PMID 23235664 (accessed October 7, 2026) Meta-analysis
  13. Dietary Supplements for Weight Loss: Fact Sheet for Health Professionals (updated May 18, 2022). NIH Office of Dietary Supplements. (accessed October 7, 2026) Government page
  14. Gibb RD, Sloan KJ, McRorie JW. Psyllium is a natural nonfermented gel-forming fiber that is effective for weight loss: a comprehensive review and meta-analysis. Journal of the American Association of Nurse Practitioners, 2023. doi:10.1097/JXX.0000000000000882 · PMID 37163454 (accessed October 7, 2026) Meta-analysis
  15. Li D, Yue L, Peng X, et al.. Yerba Mate and its impact on glycemic control and metabolic health: a systematic review and meta-analysis. Frontiers in Endocrinology, 2025. doi:10.3389/fendo.2025.1641592 · PMID 41244043 (accessed October 6, 2026) Meta-analysis
  16. Ribeiro CB, Ramos FM, Manthey JA, et al.. Effectiveness of Eriomin in managing hyperglycemia and reversal of prediabetes condition: A double-blind, randomized, controlled study. Phytotherapy Research, 2019. doi:10.1002/ptr.6386 · PMID 31183921 (accessed October 6, 2026) Randomized trial
  17. GLP-1 Probiotic (product page and claim footnotes). Pendulum. (accessed October 6, 2026) Other
  18. Lemme Reset GLP-1 Production Support Capsules (product page). Lemme. (accessed October 6, 2026) Other
  19. Warning Letter: Veronvy (MARCS-CMS 694688), December 10, 2024. U.S. Food and Drug Administration, 2024. (accessed October 6, 2026) Government page
  20. FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss. U.S. Food and Drug Administration. (accessed October 7, 2026) Government page
  21. Weight loss product notifications (tainted products). U.S. Food and Drug Administration. (accessed October 7, 2026) Government page
  22. Questions and Answers on Dietary Supplements. U.S. Food and Drug Administration. (accessed October 7, 2026) Government page
  23. FTC Announces New Business Guidance for Marketers and Sellers of Health Products (Health Products Compliance Guidance). Federal Trade Commission, 2022. (accessed October 7, 2026) Government page
  24. FTC Approves Final Order Against Telehealth Provider NextMed. Federal Trade Commission, 2025. (accessed October 7, 2026) Government page
  25. The Truth Behind Weight Loss Ads. Federal Trade Commission. (accessed October 7, 2026) Government page
  26. Berberine is being called “nature’s Ozempic” on TikTok. CBC News, 2023. (accessed October 6, 2026) News (reported facts only)

Facts checked on October 6, 2026

Educational information, not medical advice. Talk with a qualified healthcare professional about your own situation. In an emergency call 911.

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *

More posts